Starling Oncology, Inc. Warrant
STLNW
11 hedge funds and large institutions have $7.67M invested in Starling Oncology, Inc. Warrant in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.05% more ownership
Funds ownership: 4.53% → 4.58% (+0.05%)
8% less funds holding
Funds holding: 12 → 11 (-1)
31% less capital invested
Capital invested by funds: $11.2M → $7.67M (-$3.5M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$159K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$24.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$920 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
-$87.2K |
| 2 |
JG
Jefferies Group
New York
|
-$55.4K |
| 3 |
DCM
Difesa Capital Management
New York
|
-$8.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LP
1
LMR Partners
London,
United Kingdom
| $6.05M | +$159K | +172,395 | +17% |
|
|
DM
2
Deerfield Management
New York
| $625K | – | – | – |
|
|
HCM
3
Highbridge Capital Management
New York
| $529K | – | – | – |
|
|
DKCM
4
Davidson Kempner Capital Management
New York
| $159K | – | – | – |
|
|
USPCM
5
Union Square Park Capital Management
New York
| $60K | – | – | – |
|
|
WAM
6
Wolverine Asset Management
Chicago,
Illinois
| $59K | +$24.6K | +26,700 | +29% |
|
|
DCM
7
Difesa Capital Management
New York
| $58K | -$8.3K | -9,025 | -7% |
|
|
JG
8
Jefferies Group
New York
| $47.6K | -$55.4K | -60,257 | -39% |
|
9
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
| $44K | – | – | – |
|
|
AGM
10
Alpine Global Management
New York
| $13K | – | – | – |
|
|
TCM
11
Tenor Capital Management
New York
| $13K | – | – | – |
|
12
JP Morgan Chase
New York
| $4K | – | – | – |
|
|
13
UBS Group
Zurich,
Switzerland
| $3K | +$920 | +1,000 | +22% |
|
|
14
Man Group
London,
United Kingdom
| – | -$87.2K | -94,740 | Closed |
|
STLNW Hedge Fund Activity: Q2 2022 in Review
11 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology, Inc. Warrant (STLNW) for Q2 2022, worth a combined $7.67M — down 31% from $11.2M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of STLNW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was LMR Partners, adding an estimated $159K. The largest seller was Man Group, exiting entirely with an estimated $87.2K sold.
- 11 institutional investors held Starling Oncology, Inc. Warrant (STLNW) as of Q2 2022, down from 12 in Q1 2022.
- Funds reported $7.67M of Starling Oncology, Inc. Warrant stock for Q2 2022, down 31% quarter-over-quarter.
- 0 funds opened new Starling Oncology, Inc. Warrant positions in Q2 2022 and 1 closed out, a net change of -1 holder.
- The largest Starling Oncology, Inc. Warrant buyer in Q2 2022 was LMR Partners, an estimated $159K added.
- The largest Starling Oncology, Inc. Warrant seller in Q2 2022 was Man Group, an estimated $87.2K sold.
Based on aggregated 13F filings for Q2 2022.